Tick species infesting cattle in the central region of Burkina Faso: Presence of Rhipicephalus microplus less than ten years after its first identification in the Southwest part of the country.

Ticks are among the most important vectors for medical and veterinary importance in African countries, representing thus an obstacle for development and improvement of livestock production. The central part of Burkina Faso is an arid region which has a low diversity of tick species and in which Rhipicephalus microplus has been absent. This study aimed to examine ticks infesting cattle within this region, focusing on the peripheral area of Ouagadougou. Tick sampling was undertaken monthly on 30 selected cattle in the state breeding station of Loumbila, from June 2017 to February 2018. Morphological identification was carried out based on previous established keys and catalogue. A total of 1,076 ticks belonging to four genera and seven species were collected. Amblyomma variegatum (50.5%) was the most abundant species followed by Hyalomma rufipes (27.4%), Hyalomma truncatum (13.7%), Rhipicephalus decoloratus (4.5%), Hyalomma impressum (2.4%), Rhipicephalus microplus (1.5%), and Rhipicephalus sanguineus sensu lato (0.1%). The results suggested a decrease of A. variegatum and Hyalomma spp. load compared to data collected in 1996 from the same study area. Presence of R. microplus and R. decoloratus has been highlighted in the studied area for the first time. This finding highlights the relevance of regular investigations on tick species infesting livestock utilizing collaboration with different stakeholders.

Preclinical Evaluation of the Antihypertensive Effect of an Aqueous Extract of Anogeissus leiocarpa (DC) Guill et Perr. Bark of Trunk in L-NAME-Induced Hypertensive Rat.

BACKGROUND: The present study investigates the effect of an aqueous extract of Anogeissus leiocarpa (AEAL) on normotensive Wistar rats and its chronic antihypertensive effects in L-NAME-induced hypertensive rats by using a non-invasive tail-cuff model. METHODS: The effects of AEAL (50mg/kg) and NaCl 0.9% on blood pressure were investigated by daily oral administration in normotensive Wistar rats over four weeks. L-NAME-induced hypertensive rats were produced by L-NAME (40mg/kg) daily oral administration for two weeks. For chronic antihypertensive effects, induced hypertensive rats have received L-NAME in combination with AEAL (10 or 50mg/kg/day) for two following weeks. RESULTS: In normotensive rats, daily administration of AEAL (50mg/kg) has no significant effect on their blood pressure, which was similar to that of the control group. L-NAME's daily oral administration induces a progressive increase in systolic blood pressure (SBP) from 115.8 ± 7.9mmHg to 153.5 ± 4.6mmHg after two weeks, which was maintained to the end of the treatment. In L-NAME-induced hypertensive rats, AEAL (50mg/kg/day) significantly decreases the SPB from 160.0 ± 5.8 mmHg to 108.8 ± 2.7mmHg after only four days of administration. However, the lower dose of AEAL (10mg/kg) also normalized the SBP of L-NAME-induced hypertensive rats but only evident after seven days of administration. Moreover, AEAL does not effect on the serum biochemical parameters (ALAT, ASAT, CREAT, etc.) and any macroscopic adverse effect was detected on the sensible organs involved during hypertension. In the aorta rings from treated rats, AEAL (50mg/kg/day) alone or in combination with L-NAME has enhanced the vasodilation effect of acetylcholine. However, the vasodilation effect of AEAL alone or in association with L-NAME has enhanced the sodium nitroprusside effect in treated rat aorta rings after autopsy. CONCLUSION: These findings suggest that AEAL affords significant antihypertensive effects against L-NAME-induced hypertensive rats without modification of serum parameters and deleterious effects.